AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 191 filers reported holding AMICUS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $9,251,000 | +63.1% | 400,650 | -0.3% | 0.66% | +49.7% |
Q3 2020 | $5,673,000 | -6.4% | 401,793 | -0.0% | 0.44% | +6.8% |
Q2 2020 | $6,060,000 | +63.2% | 401,883 | -0.0% | 0.41% | +38.6% |
Q1 2020 | $3,714,000 | -5.6% | 401,983 | -0.5% | 0.30% | +16.0% |
Q4 2019 | $3,936,000 | +17013.0% | 404,129 | +23588.7% | 0.26% | +12750.0% |
Q1 2019 | $23,000 | +43.8% | 1,706 | 0.0% | 0.00% | +100.0% |
Q4 2018 | $16,000 | -62.8% | 1,706 | -52.0% | 0.00% | -66.7% |
Q3 2018 | $43,000 | -28.3% | 3,551 | -7.9% | 0.00% | -25.0% |
Q2 2018 | $60,000 | -4.8% | 3,857 | -8.0% | 0.00% | 0.0% |
Q1 2018 | $63,000 | -96.4% | 4,193 | -96.5% | 0.00% | -95.5% |
Q4 2017 | $1,746,000 | -4.5% | 121,303 | +0.1% | 0.09% | +17.3% |
Q3 2017 | $1,828,000 | – | 121,219 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 21,719,191 | $226,748,000 | 8.80% |
Perceptive Advisors | 27,372,917 | $285,773,000 | 8.29% |
Palo Alto Investors LP | 9,847,774 | $102,811,000 | 8.13% |
Finepoint Capital LP | 1,688,400 | $17,627,000 | 5.80% |
CM Management, LLC | 450,000 | $4,698,000 | 5.24% |
Avoro Capital Advisors LLC | 26,800,000 | $279,792,000 | 5.17% |
Artal Group S.A. | 4,000,000 | $41,760,000 | 1.78% |
Kynam Capital Management, LP | 676,849 | $7,066,000 | 1.49% |
Ghost Tree Capital, LLC | 500,000 | $5,220,000 | 1.46% |
Boxer Capital, LLC | 2,325,000 | $24,273,000 | 1.36% |